Related Experiment Video

Updated: Apr 28, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.0K

Atherosclerosis--multiple pathways to lesional macrophages

Christian Schulz1, Steffen Massberg2

  • 1Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig Maximilians-Universität, Marchioninistrasse 15, 81377 Munich, Germany. Cardiovascular Division, British Heart Foundation Centre of Excellence, The James Black Centre, Denmark Hill Campus, and Division of Immunology, Infection and Inflammatory Diseases, Guy's Campus, King's College London, London SE5 9NU, UK. DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich 80802, Germany. christian.1.schulz@kcl.ac.uk steffen.massberg@med.uni-muenchen.de.

Science Translational Medicine
|June 6, 2014
PubMed

Insights

Atherosclerosis involves inflammatory macrophages derived from blood monocytes. Understanding macrophage origins and regulation offers new therapeutic targets for this chronic inflammatory disease and its ischemic events.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pathogenesis of Atherosclerosis

Background:

  • Atherosclerosis is a chronic inflammatory disease affecting blood vessels.
  • It often leads to ischemic events like myocardial infarction.
  • Blood monocytes differentiate into macrophages, crucial in disease progression.

Purpose of the Study:

  • To discuss the origin and molecular regulation of macrophages in atherosclerosis.
  • To highlight recent conceptual shifts in understanding macrophage roles.
  • To identify potential therapeutic targets based on macrophage biology.

Main Methods:

  • Review of current literature on monocyte differentiation.
  • Analysis of molecular mechanisms regulating macrophage phenotypes.
  • Synthesis of recent findings on alternative macrophage sources.

Main Results:

  • Macrophages play a multifaceted role in atherosclerosis pathogenesis.
  • Recent research identifies novel origins and regulatory pathways for macrophages.
  • Understanding these pathways is key to developing targeted therapies.

Conclusions:

  • Targeting macrophage origin and function presents a promising therapeutic strategy.
  • Further research into macrophage heterogeneity is warranted.
  • Conceptual advancements may revolutionize atherosclerosis treatment.

More Related Videos

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

14.0K
Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages09:57

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Published on: August 12, 2019

11.5K

Related Concept Videos

Inflammation01:38

Inflammation

Overview
46.4K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
658
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
36
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
726